Unsealed Seroquel documents in US put AstraZeneca in the hot seat
This article was originally published in Scrip
Executive Summary
AstraZeneca has been embroiled in long-running product litigation surrounding its antipsychotic Seroquel (quetiapine fumarate), and it recently agreed to unseal a large batch of confidential internal documents produced in a federal court case in Florida – leading to unflattering articles in the US press based on the contents of e-mails and other communications.